Article 5MM0M Morning mail: Novavax vaccine delay, key evidence in Ben Roberts-Smith trial, celluloid classic

Morning mail: Novavax vaccine delay, key evidence in Ben Roberts-Smith trial, celluloid classic

by
Tamara Howie
from on (#5MM0M)

Tuesday: Federal government's vaccine rollout hits another hurdle. Plus: Australia's scariest homegrown film

Good morning. Australia's vaccination program has hit another hurdle and Covid testing labs are drowning" from record testing turnouts. Thankfully we have the Olympics to add some entertainment amid lockdown uncertainty - including the viral success of one wild Australian swim coach. Stay tuned to Guardian Australia's live updates throughout the day.

One of the federal government's key vaccine deals has been hit with major delays, with 51m doses of Novavax not expected until 2022. The vaccine was initially touted as a primary" vaccine, but will now form part of the booster strategy. The company, which has never brought a vaccine to market, has reported supply issues as a major hurdle and has not yet applied to the Australian Therapeutic Goods Administration (TGA) for approval. The government is now focusing on securing more Pfizer shots, which will now be made available for supermarket workers in south-west Sydney. NSW will also set up walk-in clinics for AstraZeneca vaccine shots in south-west and western Sydney. Premier Gladys Berejiklian foreshadowed the state's strict lockdown would continue but with some possible changes after the state recorded 145 new cases and two deaths yesterday.

Continue reading...
External Content
Source RSS or Atom Feed
Feed Location http://feeds.theguardian.com/theguardian/world/rss
Feed Title
Feed Link http://feeds.theguardian.com/
Reply 0 comments